LinkedIn image ad examples

Clinical data fragmentation is over! CRScube boosts data quality, slashes query volume, and accelerates database lock.

Your focus is delivering lifesaving treatments. Ours is supporting your trials with smarter technology.

We deal with rare blood disorders every day. Partner with experts to care for your patients.

At Chronetyx, our belief is If the science exists to improve patient care, providers should use it.

Bigger savings, competitive reimbursements, stronger advocacy. Join EPN’s PSAO today and empower your independent pharmacy to reach new heights.

You strive to provide the best for your patients—we give you the data to do it. Chronetyx Laboratories combines sophisticated LIMS, advanced bioinformatics, and a multidisciplinary team of pathologists, scientists, and engineers to deliver personalized diagnostics at scale. Explore how our tailored testing solutions can help you build a higher standard of care today.

FACS and hybridoma workflows have delivered countless antibodies, but every sort, expansion and retest adds time and attrition. Our latest ebook explores how function-first screening shortens the path from cell to confirmed antibody. Download the eBook below. 👇

The antibody you need might come from one cell in a million, and proxy-based screens can lose it before it's ever tested. Our latest ebook explains why rare secretors slip through, and how to capture them. Download the eBook below. 👇

Looking for provider-specific solutions? Evoluciona Pharma offers more categories in one place. Learn more about our provider-specific workflows

Looking for provider-specific solutions? Evoluciona Pharma offers more categories in one place. Learn more about our provider-specific workflows

Early development decisions depend on more than a successful first dose. CTC combines study design, clinical pharmacology, hospital-based clinical conduct, biometrics and reporting within one delivery model — helping sponsors move from protocol to interpretable data with fewer operational handovers.

CTC combines full-service CRO capabilities with an in-house Site Network across Sweden and the Netherlands. Recruitment, site operations, monitoring, data and safety are coordinated within one organisation — giving sponsors clearer oversight and fewer operational handovers.

Every research program begins with a question. What is driving the disease? How does a genetic change affect cell behavior? How might a potential therapy influence the biology? The model used to investigate those questions matters. Researchers around the world can work with our scientists to develop human-relevant cell models around specific study objectives—from patient-derived iPSCs and genome-edited lines to differentiated cell types and advanced 3D models. The goal is not simply to create a model that performs consistently. It is to create one that helps researchers study the biology that matters to their program. Start with the question. Build the model around it. Contact an iXCells scientist to discuss your next research program. https://lnkd.in/gi83im96/?utm_campaign=Boost_Post_WebsiteVisits_Oct6,2026&utm_source=linkedin&utm_medium=paid&utm_id=1217950746&hsa_acc=515356232&hsa_cam=1217950746&hsa_grp=910079846&hsa_ad=1633244966&hsa_net=linkedin&hsa_ver=3

Patiënten snel duidelijkheid geven? Bij DC Klinieken Hengelo kunnen uw patiënten op korte termijn terecht voor endoscopisch onderzoek in een vertrouwde omgeving. Verwijs eenvoudig via ZorgDomein

Une reconnaissance qui nous rend particulièrement fiers. 🧡 Notre présidente Caroline Biron figure parmi les 25 dirigeantes des plus grandes entreprises québécoises en 2026, selon Les Affaires. Cette distinction souligne son parcours à la tête de Biron et le chemin parcouru au fil des années pour faire grandir l’entreprise, faire avancer la santé et placer l’humain au cœur de nos actions. Et avec Caroline, c’est toute une équipe qui contribue à faire de cette vision une réalité, jour après jour. 👉 https://lnkd.in/gd2Nnj99

Henry Schein and Chooch AI Bring Full-Service AI Inventory Management to Health Systems and Medical Organizations Nationwide. https://lnkd.in/g7dYjfJb Healthcare Facilities Can Access Chooch’s AI-Powered Inventory Detection and Management Platform, Which Can Be Paired with Henry Schein’s Complete Supply Chain Services

Strong research requires more than individual capabilities. It requires the scientific expertise to apply them effectively. Across six core services, iXCells supports researchers with specialized knowledge, technical experience, and the flexibility to meet the needs of complex discovery programs: iPSCore An all-in-one iPSC platform for generating predictive, human-relevant models that help drive preclinical drug discovery forward. iPSC Cell Generation Custom reprogramming of somatic cells into fully characterized iPSC lines using non-integrating methods. Genome Editing CRISPR-based editing in iPSCs for isogenic disease models and precision target validation. iPSC Differentiation Reproducible differentiation into neurons, cardiomyocytes, hepatocytes, and other specialized cell types. Custom Cell Isolation Cell isolation tailored to your tissue source, donor criteria, and research application needs. High-Throughput iPSC Scalable, high-volume iPSC screening platforms built for speed, consistency, and drug discovery demands. From model generation and genome engineering to differentiation, scale-up, and custom research support, each service is backed by scientists who understand the biology and the objectives behind the work. Six Core Services. Scientific Expertise Behind Each. Contact an iXCells scientist to learn more. https://lnkd.in/gi83im96/?utm_campaign=Boost_Post_WebsiteVisits_Oct6,2026&utm_source=linkedin&utm_medium=paid&utm_id=1217950746&hsa_acc=515356232&hsa_cam=1217950746&hsa_grp=910079846&hsa_ad=1633381536&hsa_net=linkedin&hsa_ver=3 #iPSC #GenomeEditing #CellBiology #DiseaseModeling #DrugDiscovery #LifeSciences

Voor een gastroscopie of coloscopie snel terecht? Verwijs uw patiënt naar DC Klinieken Hengelo. Korte wachttijden en specialistische MDL-zorg in een vertrouwde omgeving. Verwijs eenvoudig via ZorgDomein

Dilated cardiomyopathy is a leading cause of heart failure and heart transplantation. 🫀 BAG3 variants account for up to 5% of genetically resolved DCM, and the genetics are increasingly well understood. So why is it still so hard to find therapies? In large part, because the models haven't kept up. 2D cultures don't generate contractile force, and animal models don't fully reproduce human cardiac disease. For DCM, a disease of failing heart muscle, force is the phenotype that matters. Curi Bio and Greenstone Biosciences set out to measure it. We started with a patient-derived iPSC line carrying a BAG3 frameshift mutation, from a donor whose heart was pumping at a 12% ejection fraction. We built it into 3D human engineered heart tissues and profiled them on our Mantarray™ and Nautilai™ platforms. The tissues reproduced the patient's disease. Our study also raised the questions that matter most for therapy development: ➡️ Is the deficit in the heart's contractile machinery, or in how that machinery responds to calcium? ➡️ How does a diseased heart tolerate a drug that healthy models say is safe? ➡️ What can a single cohort of tissues reveal across multiple drug challenges and 28 days in culture? Join us on October 28, when Dr. Todd Herron and Dr. Thomas Leahy, PhD will share the answers, and what they mean for modeling inherited cardiomyopathies in human tissue. 📅 Wednesday, October 28 · 8 AM PDT (11 AM EDT / 4 PM CET) 🔗 Register today: https://hubs.ly/Q04z5ddF0 #DilatedCardiomyopathy #HeartFailure #CardiacSafety #iPSC #3DTissueModels #RareDisease #NAMs #DrugDiscovery #CuriBio #GreenstoneBiosciences

A Breakthrough Therapy designation only matters if we can get treatment to the patients who need it following approval. We need treatment frameworks that maintain high safety standards and ensure feasible implementation across diverse healthcare environments. In the latest edition of Forward Focus, I explore how we might bridge breakthrough clinical science and real-world delivery through evidence-led, scalable care models. Read the article here: https://bit.ly/4yXKQz5 #MentalHealth #DefiniumTherapeutics #Psychedelics #HealthcareInnovation #MDD #Depression #GAD #Anxiety

✨ En #CentroMédico sabemos que la prevención es el primer paso hacia el bienestar. Durante octubre, te acompañamos en la lucha contra el cáncer de mama con un 50% de descuento en mamografías. Haz de tu salud una prioridad, porque tu vida y tranquilidad son lo más importante. 💗 📅 Vigente hasta el 15 de noviembre. Realízate la mamografía en: Zona 10, Cardales de Cayalá, Condado Concepción y Las Puertas San Lucas. 📞 2279-4949 #CentroMédico #Especialistas #Cuidado #Salud.

💪 Rehabilitación en hospital y en tu hogar. Recibe atención personalizada con programas que se adaptan a ti, ya sea en nuestras instalaciones o en tu casa. Conoce nuestros servicios: https://lnkd.in/e-e6fEYi. #CentroMédico #Especialistas #Cuidado #Salud.

✨1 Hour Race-Approved CE Course ✨ Healing with Light: Laser Therapy for Mobility, Pain, & Beyond Join Dr. Rachel Cain, a leading veterinarian in rehabilitation and integrative medicine, for an in-depth course exploring the clinical benefits of Class IV laser therapy. 📌 What You’ll Learn: Overview of Laser Therapy & its biological effects Therapeutic benefits for canine and equine patients Practical clinical applications & real-world case examples 👩⚕️ Meet Your Presenter: Dr. Cain is a compassionate veterinary specialist with residency training in Sport Medicine & Rehabilitation. She blends science with holistic care to enhance healing and patient outcomes. 💡 Don’t miss this opportunity to earn a 1 Hour Race credit & expand your clinical knowledge and see laser therapy in action! 🔗 Register here: https://lnkd.in/gEjcEYnx #DVM360 #CuttingEdgeLasers #CECredit #VeterinaryContinuingEducation #AAVSB

Em operação com força de trabalho intensiva em campo, coparticipação costuma gerar um efeito silencioso: o colaborador tem o convênio, mas evita ir ao médico por receio de desconto em folha. O resultado aparece depois, e mais caro - cuidado simples que virou caso grave, atestado mais longo do que seria necessário, e uma sensação de que o benefício "não vale a pena" mesmo quando a empresa investe pesado em campanhas de prevenção. Empresas que já enfrentaram esse padrão encontraram forma de reduzir esse atrito sem abrir mão de controle de custo. Vamos conversar sobre como reduzir o receio de usar o plano de saúde na operação do Grupo Moreno?